Managing anticoagulation in patients receiving implantable cardiac devices

Author： Mangrolia Neil   Nayar Vikrant   Pugh Peter J  

Publisher： Future Medicine

ISSN： 1479-6678

Source： Future Cardiology, Vol.8, Iss.3, 2012-05, pp. : 393-411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

A substantial proportion of patients who undergo cardiac rhythm device implantation receive anticoagulation to prevent thromboembolism. Many patients have coexisting cardiovascular diseases treated with antiplatelet therapy. Anticoagulation may increase the risk of hemorrhagic complication, while withdrawal of anticoagulation may increase thromboembolic risk. In this article, we review and describe the available evidence, in order to inform best practice.

Related content

Ischemic Stroke or Systemic Embolism After Transseptal Ablation of Arrhythmias in Patients With Cardiac Implantable Electronic Devices

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 4, 2016-04 ,pp. : n/a-n/a (NaN)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Perioperative Thromboprophylaxis and Anticoagulation in Patients Undergoing Non-Cardiac Vascular Surgery

By  

Current Vascular Pharmacology, Vol. 9, Iss. 1, 2011-01 ,pp. : 48-53 (6)

Bentham Science Publishers

Access to resources Recommend Favorite

The pathway to physician reimbursement for cardiac implantable electronic devices (CIEDs): a history and brief synopsis

By Roka Attila  

Journal of Interventional Cardiac Electrophysiology, Vol. 36, Iss. 2, 2013-03 ,pp. : 137-144 (8)

Springer Publishing Company

Access to resources Recommend Favorite

Multi‐Center, Community‐Based Cardiac Implantable Electronic Devices Registry: Population, Device Utilization, and Outcomes

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 3, 2016-03 ,pp. : n/a-n/a (NaN)

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Descriptive Evaluation of Routine Complete Blood Count Monitoring in Patients Receiving Anticoagulation Therapy

By Anich Kandace   Witt Daniel   Delate Thomas   Shanahan Roberta   Patel Rachana  

Journal of Thrombosis and Thrombolysis, Vol. 20, Iss. 3, 2005-12 ,pp. : 183-188 (6)

Springer Publishing Company

Access to resources Recommend Favorite